01 1Allite (Shanghai) Pharmaceutical Technology
01 1CARFILZOMIB
01 1China
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2023-12-26
Pay. Date : 2023-10-12
DMF Number : 38486
Submission : 2023-09-06
Status : Active
Type : II
20
Jiangsu Xidi Pharmaceuticals Co Ltd, based in China, is a pharmaceutical company.
One of their notable products is CARFILZOMIB, with a corresponding US DMF Number 38486.
Remarkably, this DMF maintains an Active status since its submission on September 06, 2023, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of December 26, 2023, and payment made on October 12, 2023, indicating their dedication to facilitating drug approvals, Categorized as Type II
